Source: Telomolecular Corporation
Date: July 2, 2007
Summary:
In an official news release, Telomolecular Corporation explains its telomere regenerative medicine therapy and how it might achieve some of the potential healing outcomes promised by stem cell therapy without ethical controversy:
"Nanotechnologies involving chromosomal telomeres, such as those acquired and developed by Rancho Cordova, Calif.-based Telomolecular, can achieve everything that stem cell therapies achieve but without many of the drawbacks. Telomeres are protein compounds that act like caps on the ends of chromosomes and make sure that the DNA replication process ends the way it's supposed two when a cell divides. But every time a cell divides the telomeres shorten and eventually they become exhausted. Telomere exhaustion has been linked with numerous age-related diseases and with cancer. Stem cell therapy attempts to address this problem by growing new tissue with renewed telomeres in place of the tissue with exhausted telomeres. But stem cell therapy can lead to development of cancerous or abnormal tissues."
